The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II trial has recently been ...

Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives ...

However, when several insiders are buying, like in the case of Where Food Comes From, Inc. (NASDAQ:WFCF), it sends a favourable message to the company's shareholders. Although we don't think ...

SINGAPORE] Over the four trading sessions from Jun 13 to 18, institutions were net sellers of Singapore stocks, with net ...

All resolutions recommended by the Board of Directors approved (quorum: 27.21%). Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2025 - GENFIT (Nasdaq and Euro ...

Boston-based Verve Therapeutics is a Nasdaq-traded company focused on genetic medicines for cardiovascular disease.

An ABC investigation finds that among investments raking in the dollars for the Australian-founded Macquarie Group is the ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health ...

Mayne Pharma holders have voted overwhemingly in favour of Cosette's $600 million offer that's no longer on the table. See you in court.

The elimination of 3,500 full-time employees at the FDA risks undermining the very innovation and domestic capacity the ...